Peer Review History
| Original SubmissionOctober 6, 2021 |
|---|
|
PONE-D-21-32083Addressing zoonotic diseases in Jordan: the inextricable link between health and peacebuildingPLOS ONE Dear Dr. McAlester, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rebecca Lee Smith, D.V.M., M.S., Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General Comments The authors work is an interesting that they tried to develop a customized tool consisting of various relevant criteria used for prioritizing zoonotic diseases by considering the impact of violence and migration of people on the emergence, occurrence and spread of Zoonotic diseases within the context of Jordan situation. A combination of different methods was used, and the manuscript is written well and exhaustively. The authors also provided supplementary supporting files. However, there are many points that need further clarification before publication. My assessments, questions, and suggestions are provided here as follows point by point under each section of the manuscript which might the authors can consider during the revision of the manuscript. Title The term “addressing” is too generic and not reflecting the content and essence of the study. Addressing zoonotic diseases technically connected with intervention which might be prevention and/or control of diseases with measurable actions by prioritizing the diseases and allocating available resources. The overall aim of the study is just prioritizing zoonotic diseases by considering the role of peace building, health and COVI-19 in the list of zoonotic diseases in addition to the criteria used by other OHDP tools. However, the role of health and peace in prioritizing zoonotic diseases within the framework of the new modified tool was not considered and the linkage is not clear. Consider modifying the title. Abstract The author should clearly state the objective of the study after providing 1-2 statements that justify the main reason(s) for conducting this study. -Lines 25-29 – It seems that the main aim of the study is providing a conceptual framework that situates health and peace building for prioritizing the zoonotic disease. But, elsewhere in the manuscript, it is stated that the aim is to prioritize zoonotic diseases using modified OHZDP as a tool. Thus, the author should clearly state the objective of the study after providing 1-2 statements that justify the main reason(s) for conducting this study. -The authors are highly skewed at the beginning that health and peace building and Covid 19 can change the proposed and commonly used OHZDP process. I think these factors (Health and peace building) should be considered during criteria setting and weighing the criteria for evaluations of the selected diseases based on the literature and expert opinion for prioritize zoonotic diseases. Covid 19 should be treated as one disease and evaluated against these criteria (health and peace) and the other criteria. If the interest is to show the role of health and peace building, the author should indicate the degree of weight allocated to them during criteria weighing and why these bear the higher/highest weight under Jordan Situation. this information is not mentioned in the manuscript. Introduction Generally, it is too long and is very difficult for the readers to easily understand the intent of the study. Consider the following points for revision: -As you did in the Abstract, begin with highlighting about the zoonotic diseases and then, make linkage with peace building, health inequity and development followed by rationale for designing and conducting this study within the context of Jordan. Here, you should vividly justify or argue why developing new proposed tool is needed in comparison to the OHZDP suggested by WHO that have been used in many countries. -Condense paragraphs 1-4 to 1-2 paragraphs by only showing the interlinkage of peace building, health inequity and development with zoonotic diseases. As long as you cited the relevant references, the theoretical background can be left for readers for further reading. - line 60.-Is “she” refers to “ Woehrle 3”. If that is the case, 3 represents CDC website. Cross check the citations and references across the document. After correction, replace “she” with “The author”. Lines 97-105- Combine this paragraph with the last paragraph (line 136-148) as a rationale for this study. Lines 86-88 and 115-122- In lines 86-88, animal is mentioned as a reservoir for COVID 19 and considered as a zoonotic disease with no supporting evidences from the literatures. In contrary to this assumption, you mentioned that the role of animal as intermediary host is yet to be identified and established. Which one is true? Under these scenarios, how you can argue the limitation of a study by Kheriallah and considered COVID 19 in the list of Zoonotic diseases? Can you provide compelling evidences particularly in Jordan that supports animals are one of the sources of COVID 19 infection for humans and vice versa to consider it as a zoonotic disease? Mind that your focus is zoonotic diseases!!! Lines 106-107- it is interesting that the authors scholarly acknowledged the work of Kheirallah et al 2021 to avoid release of overlapping publications with similar aims from one country within short period of time. You mentioned your work is conducted independently and you are interested to consider the prioritization of zoonotic diseases by including COVID 19 which was the limitation of Kheirallah et al. I do not think that this should not be a justifiably reason to initiate and conduct this study. If you think the work is independent, you should not raise this point, Kheirallah et al work, in the introduction as a justification for designing and conducting this study which is not actually the case. The point here is why you did not consider this work as one tool in the analysis of previously published OHZDP tools once you knew the publication before submission of this manuscript for publication. Rather, as you mentioned and discussed it should be addressed in the discussion section. -Lines 123-135: The justification of considering the potential impact of increasing in number of refugees on the increasing risk of zoonotic infection is important rationale for this study which makes Jordan situation peculiar. -Can you explain how this study overcomes the limitation on the lack of data regarding zoonotic diseases in Jordan mentioned by Kheirallah et al. In this study, you also mentioned under study limitations lack of data on the relationship between health and peace building on the incidence of zoonoses in Jordan. -Line 127. You argued that ….the groups are not inclusive enough to comprehensively represent the spectrum of issues in Jordan as the experience of refugees was not considered? If not inclusive, which sector/organization(s) should have been considered to address this gap? How your study overcome this gap? Line 147- delete the last sentence. Methodology -As mentioned in the introduction, the potential rationale for this study is the under representation of the role of health and peace which can potentially influence the rank of priority zoonotic diseases in Jordan. You justified importance of the use of the proposed OHDP in countries with limited data on zoonotic diseases. Why you did not use the ODHP by considering this criteria and providing evidences, of course as a complementary to study Kheirallah et al, that show the significance of the criteria may be by allocating high weight which can potentially shift the rank of zoonotic diseases in Jordan? I do not see the significance of the thematic and statistically analysis of the previous tool used in different countries to see the similarity and predict the situation in Jordan. One of the significance of the use OHZDP is prioritizing the zoonotic diseases within the context of each country by involving the key stakeholders from various sectors and establishing inter-sectorial cooperation to combat the priority diseases. - It would be nice if you separately present the data analysis i.e. pull all the analyses under one sub headlining-Data analysis. Line 165: To talk about sample size there should be a sampling frame from which the sample can be drawn based on selected probability or non-probability sampling technique. How, the 12 tools were selected? This is also mentioned in the limitation section. Were only 12 countries prioritized zoonotic diseases using OHDZP? The general framework in all of the 12 countries is similar in using the OHDZP with minor difference in the number of criteria and measurement scales. Can we say that they are different tools? Line 169: We then, 171: The framework is the same for all where they used the WHO proposed OHZDP. Replace framework as”……groups countries based on similarity in selection of criteria and measurement questions….” 172. Put “to be operating under a similar framework” after Tanzania. Six countries,… 177: What are those three category intercepts? Specify them. 178-180: Why this is possible in practical sense? 181-182: Re-phrase the sentence and clearly mention the dependent and independent variables for the logistic regression analysis performed. Specify the three categories and the baseline category. 191-193: Re-phrase the sentence. 196: How the data was scaled? Add a brief description. 210-213: Only incidence data? No prevalence? Is it possible to indicate how the incidence of the diseases were diagnosed and reported (clinical, laboratory, confirmation?) -citation for OIE database 214-216: What the “immediacy” really refers in terms of measurement of diseases? Time? -1) Delete “the disease needed to have” then, add “from animals and humans” after….span,….. 2) ….reported in humans and animals population. 217: Delete “ this resulted in in seven zoonoses” from here and take to result section. 218-221: Including but not limited? this is confusing and please add the other search databases searched for transparency. Did you use any systematic way to search from these databases? Any key search terms used during search? Selection criteria? All these are worth mentioning. 223: …this? you mean data on list of zoonoses? Mention what “ this “ refers. Here you are in another heading ( Pahse3). Lines 224-225: The statement is not complete and needs re-phrasing. Indicate for what purpose the data was used. To construct modified zoonotic diseases prioritization tool? What is the central point for evaluating for the cultural compatibility between Jordan and other countries given the objective of the study (impact of violence on health)? What is the advantage over the stakeholder opinion based prioritization? Add citation for the data collected. Line 235: the experience of covid-19? Is it specifically mentioned in the methodology? Covid 19 should be treated as one of the diseases and evaluated based on the identified criteria and weight given. -Start with we constructed a modified zoonotic prioritization tool Line 240-242: Again- including but not limited? this is confusing and please add the other search databases searched for transparency. Did you use any systematic way to search from these databases? Any key search terms used during search? Selection criteria? Provide website addresses for each database searched. Line 242- The criteria and the questions were identified based on the thematic and descriptive analyses. But, it seems that the authors answer (score) each questions of measurement of the criteria for each disease based on literature. I do not think that the authors can get clear information to score each questions. It would have been nice if this was validated by the stakeholders. Line 246: Just before the result, mention how your question of peace/violence is addressed in the modified tool to generate a new list of priority diseases. Line 254: Indicate that the used criteria in all countries were not the same. Line 255: Based on the thematic analysis, we found six criteria and 12 categorical questions (Table 1). Lines 258-259: “ This suggests……….zoonotic diseases” Take to discussion section. Lines 259-261: Mention the countries. The fifth criteria, bioterrorism potential,….four countries (XXXX) and five countries (XXXXX). Lines 267-273: move to discussion section. Line 274: Rephrase: and start as “Table 2 summarizes the criteria weighting used by each country. Lines 278-280. Avoid interpretation in the result section and consider it discussion. Line 279: Significantly (XX? quantify). Line 286: Revise the table by adding row/column for the weight allotted for each criterion by each respective country and also mention in the methodology how the total weight is computed. Line 290- Delete confirmatory factor analysis and rephrase as “ Table 3 shows the confirmatory factor analysis results for each one factor model fit…….” Line 293: Table 3: add footnotes for SRMR, CFI& SE Line 296: No heading for phase 1 results. Be consistent. Lines 297-366: This is the result section not discussion. Present briefly in one paragraph the identified relevant zoonotic diseases and delete the detail description from here. You can provide the citations for each disease as a supplementary file. You can take some of the information from here and use them when discussing the results of phase 3 for the top priority diseases. Lines 360-366: These should be rather part of the methodology not the result. Line 367: Describe the major findings summarized in Table 4 in text before the table and refer to Table 4 for detail. Lines 370-372: Already mentioned in the methodology. Here mention about the new tool focusing the findings as a result of the modified criteria and measurement/questions….. -Be consistent for using questions Vs categorical variables Vs candidate variables. Lines 375-385: Take to the discussion section. Line 389: Again the same question: Now it is clear that the criteria, the weight and the scoring of the scale for each question are based on studies in previous country according to your thematic analysis. How the authors assigned a score for each disease and prioritized the diseases in absence of stakeholder validation? Line 391: Discussion next to Table 6 I would suggest that the authors treat the discussion section separately as a main heading by take into account the following points in sequential manner: 1.Re-iterate the purpose of the study in the first paragraph 2.Followed by discussing about the new modified tool and its advantage over the Keheiriela et al study that based on the WHO proposed tool 3.How the health and peace building issues are important in prioritizing zoonotic diseases under the Jordan situation 4.Description about the relevant zoonotic diseases in Jordan and detail discussion only for the top priority by implicating the need for targeting these diseases to initiate prevention and control. Lines 443-454: It is not clear how the authors try to address the impact of peace/migration on the occurrence, emergence and spread of zoonotic diseases. In the modified OHZDP, there is no data summarized in the result section that shows the importance of including drivers of health linked with violence. Can you explain this a bit further? Line 457: The issue of health is should e situated along with the other factors such as economic crisis when it comes to the case of refuges. Line 466: Delete the discussion from here and move some of the information back to the discussion section where it fits and make your conclusion remarks separately. Lines 472-275: I do not agree with this statement. I argue that 1) the weight allotted to each criterion cannot be considered uniform for each disease, and 2) your modified tool is also totally depended on the previously proposed tool used by different countries. May you further explain what are you communicating here? **************************** Reviewer #2: A much appreciated interdisciplinary approach to focus on OneHealth and Refugees at one time. The way COVID has but us all at risk makes it difficult for governments in developing countries to see things under the OH theme. That being said, it is critical to focus the attention on refugees first in the introduction and to provide number of refugees in Jordan. Since 2010, Jordan has accepted around 1.5 million Syrian refugees (600,000 are officially registered with UNHCR and the rest are not registered). Three main camps are in Jordan for Syrian refugees: Zaatri, Azraq are the main two within local populations, or within a short distance. Zaatri was built and made ready in days and is not organized as a camp as that for Azraq. There are real issues with clean water, sewage, and essential services. This is a real impact on OH and peacekeeping. Especially when knowing that 80% of Syrian refugees live outside camps within local (host) community. Therefore, the results may be biased towards camp residents as data on host community refugees are extremely limited. This is another major limitations for this study. Jordan has also accepted Iraqi refugees, and small proportions of refugees from Yemen, Libya, among others. How would this be considered into the results of the study. Also, Jordan has Palestinian refugee camps established since the 70s. Such camps have the same crowdedness and lack of clean water and sewage systems. Yet, their impact is not considered in the paper. This is another limitation for this study. Apparently, These limitations are much needed. Line 415: Increase in number of TB may be due to available funding to study the disease and provide surveillance activities. How would this change the study results? line 466: a new zoonotic priority list could be easily established in Jordan using the same tool in Kheirallah's study. SO this statement is overestimation of the results. I think the sentence should be that this is the first tool to connect peacekeeping to zoonosis. Line 472: Our list was based on experts within the OH field, especially MoH and MoA. They even changed the final prioritization by moving some diseases up the list based on their expertise in the field. This was not part of the presented results as it depended on theoretical experience not on-the-ground one. In table 7, under Construction of Tool, what we utilized in Kheirallah et al was a standardized CDC workshop tool that prioritized Zoonotic diseases in Jordan. This has an advantage of comparing countries' priority list and allow standardized methods for comparing results over time. Table 7: Prioritized List. We actually used regional prospective as Jordan is really connected to Syria, Iraq, Egypt and the other Arab states including Saudi Arabia, Qatar, and UAE. So our initial list was regional based on national needs. Line 495: Socio-economic were a major concern during the workshop, Still, we did not see a major effect as this was conducted before COVID. If things were to be done today, SE would be a major issue and will have a higher weight. Line 507: great point. Can you further elaborate and include in the major conclusion. Another limitation is the utilization of data to withdraw data on zoonotic diseases in Jordan. KNowing that such data is not complete, not funded, does not have properly funded surveillance tools, makes it hard to rely on the available data to draw conclusions. One major comment from working with OH in Jordan is the lack of ministry of Environment in any of the OH related activities. MoH has an environmental health unit and it covered all activities related to the environment. This is a major issue that surfaced during COVID. As such, Jordan recently established the Jordan CDC. The center is expected to take the lead in OH. In the presented manuscript, the authors based their theory on numbers reported by multiple partners including Jordan MoH. During the workshop we conducted in Jordan, it was clear that surveillance data on zoonotic diseases are lacking in Jordan. For example, zoonotic diseases are treated in the camp and never make it to MoH but rather to UNHCR. The health system within the camp is not related to MoH directly except for COVID, which is a recent approach given the political covid issues. In the tool that was used in Jordan, the CDC provided a guideline for which participants actually provide the 5 core questions and their scoring system. So the questions and their answers were as provided by the local stockholders. Not sure how would this change, if any, the scope of the statistical analysis used. For Hofstede Cultural Typology, what data is provided? can you provide examples of data? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Khalid A Kheirallah [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Situating zoonotic diseases in peacebuilding and development theories: prioritizing zoonoses in Jordan PONE-D-21-32083R1 Dear Dr. McAlester, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Rebecca Lee Smith, D.V.M., M.S., Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript is significantly improved! I would like to acknowledge the authors for addressing the given comments and suggestions. Nonetheless, it would be so important to address the following minor comments: 1.The manuscript requires language edition. There are many instances where the statements are not correct grammatically. Just some examples, Abstract: -We employ (L29) - We use (L31) -We expand(L32) -We undertake(L33) -We apply(L38) -We find(L39) -We use (L36) Introduction: We write (L114) We outline (L116) etc……. consider changing them into past tense form. 2.The data analysis only refers to the analysis of OHZDP tools. You might also pull the analysis of the literature review and the data from the Hofstede tool. Otherwise change it back to the original manuscript (Phase 2- Analysis/Evaluation of previous OHZDP tools) 3.Line 141-142; Delete “…and producing of a list of relevant zoonoses in Jordan” 4. Results and Discussion: you might consider deleting the sub-headings as you have already mentioned the phases in the methodology section. Also delete the subheading “Comparison with recent research” which is all about discussion. Lastly, I strongly recommend the publication of this manuscript after language edition. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Fanta D Gutema Reviewer #2: Yes: Khalid Kheirallah |
| Formally Accepted |
|
PONE-D-21-32083R1 Situating zoonotic diseases in peacebuilding and development theories: prioritizing zoonoses in Jordan Dear Dr. McAlester: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Rebecca Lee Smith Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .